American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency.

This document serves to summarize the issues and the American Thyroid Association (ATA) position regarding the use of potassium iodide as a thyroid blocking agent in the event of a nuclear accident. The purpose is to provide a review and updated position statement regarding the advanced distribution, stockpiling, and availability of potassium iodide in the event of nuclear radiation emergencies in the United States.

[1]  E. Akl,et al.  The First Meeting of the WHO Guideline Development Group for the Revision of the WHO 1999 Guidelines for Iodine Thyroid Blocking. , 2016, Radiation protection dosimetry.

[2]  H. Miska.  Evaluation of the Response to the Fukushima Accident , 2016, Health physics.

[3]  S. Yasumura,et al.  Comparison of childhood thyroid cancer prevalence among 3 areas based on external radiation dose after the Fukushima Daiichi nuclear power plant accident , 2016, Medicine.

[4]  M. Hosoya,et al.  Comprehensive Survey Results of Childhood Thyroid Ultrasound Examinations in Fukushima in the First Four Years After the Fukushima Daiichi Nuclear Power Plant Accident. , 2016, Thyroid : official journal of the American Thyroid Association.

[5]  R. Stone.  NUCLEAR SAFETY. Near miss at Fukushima is a warning for U.S. , 2016, Science.

[6]  Taikan Oki,et al.  Was the Risk from Nursing-Home Evacuation after the Fukushima Accident Higher than the Radiation Risk? , 2015, PloS one.

[7]  M. Akashi,et al.  Implementation of iodine biokinetic model for interpreting I-131 contamination in breast milk after the Fukushima nuclear disaster , 2015, Scientific Reports.

[8]  T. Shimura,et al.  Public health activities for mitigation of radiation exposures and risk communication challenges after the Fukushima nuclear accident , 2015, Journal of radiation research.

[9]  S. Nagataki,et al.  A review of the Fukushima nuclear reactor accident: radiation effects on the thyroid and strategies for prevention , 2014, Current opinion in endocrinology, diabetes, and obesity.

[10]  Hui Zhang,et al.  Radiation-Driven Migration: The Case of Minamisoma City, Fukushima, Japan, after the Fukushima Nuclear Accident , 2014, International journal of environmental research and public health.

[11]  M. Akashi,et al.  Guidelines for iodine prophylaxis as a protective measure: information for physicians. , 2014, Japan Medical Association journal : JMAJ.

[12]  K. Blum,et al.  Managing Terrorism or Accidental Nuclear Errors, Preparing for Iodine-131 Emergencies: A Comprehensive Review , 2014, International journal of environmental research and public health.

[13]  L. Braverman,et al.  Consequences of excess iodine , 2014, Nature Reviews Endocrinology.

[14]  Levin Rj,et al.  Incidence of thyroid cancer surrounding Three Mile Island nuclear facility: the 30-year follow-up. , 2013 .

[15]  Thomas V Inglesby,et al.  After Fukushima: managing the consequences of a radiological release. , 2012, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[16]  Fabian T. Camacho,et al.  Thyroid cancer characteristics in the population surrounding three mile island , 2012, The Laryngoscope.

[17]  Steven L Simon,et al.  Response of the U.S. Department of Health and Human Services in Protecting Civilian Americans in Japan during the Fukushima Nuclear Crisis , 2012, Health physics.

[18]  A. Schneider,et al.  Potassium iodide prophylaxis: what have we learned and questions raised by the accident at the Fukushima Daiichi Nuclear Power Plant. , 2012, Thyroid : official journal of the American Thyroid Association.

[19]  K. Tanigawa,et al.  Loss of life after evacuation: lessons learned from the Fukushima accident , 2012, The Lancet.

[20]  Evelyn O Talbott,et al.  Cancer incidence among residents of the Three Mile Island accident area: 1982-1995. , 2011, Environmental research.

[21]  H. William Strauss,et al.  The Japanese Tsunami and Resulting Nuclear Emergency at the Fukushima Daiichi Power Facility: Technical, Radiologic, and Response Perspectives , 2011, The Journal of Nuclear Medicine.

[22]  L. Guey,et al.  A 25 year retrospective review of the psychological consequences of the Chernobyl accident. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[23]  V Saenko,et al.  The Chernobyl accident and its consequences. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[24]  A. Bouville,et al.  RADIATION DOSIMETRY FOR HIGHLY CONTAMINATED BELARUSIAN, RUSSIAN AND UKRAINIAN POPULATIONS, AND FOR LESS CONTAMINATED POPULATIONS IN EUROPE , 2007, Health physics.

[25]  J. Lubin,et al.  Proliferative activity of human thyroid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure. , 2006, The Journal of clinical endocrinology and metabolism.

[26]  Peter Jacob,et al.  Cancer consequences of the Chernobyl accident: 20 years on , 2006, Journal of radiological protection : official journal of the Society for Radiological Protection.

[27]  G. Voigt,et al.  Post-Chornobyl Thyroid Cancers in Ukraine. Report 1: Estimation of Thyroid Doses , 2005, Radiation research.

[28]  K. Kopecky,et al.  Risk of Thyroid Cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station Accident , 2004, Radiation research.

[29]  J. Bidart,et al.  Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  K. Kopecky,et al.  Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. , 2003, International journal of epidemiology.

[31]  J H Lubin,et al.  Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. , 1995, Radiation research.

[32]  Ilya A Likhtarev,et al.  Analysis of the effectiveness of emergency countermeasures in the 30-km zone during the early phase of the Chernobyl accident. , 1994, Health physics.

[33]  J. Wolff,et al.  Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. , 1993, The American journal of medicine.

[34]  V. Beral,et al.  Administration of stable iodine to the population around the Chernobyl nuclear power plant , 1992 .

[35]  L. Braverman,et al.  The use of iodine as a thyroidal blocking agent in the event of a reactor accident. Report of the Environmental Hazards Committee of the American Thyroid Association. , 1984, JAMA.

[36]  L. Lipworth,et al.  Suppression of thyroid radioiodine uptake by various doses of stable iodide. , 1980, The New England journal of medicine.

[37]  W. Apple.  DepartmentsMedicaid Hasn't Kept Pace—Treat Pharmacy Equitably , 1979 .

[38]  Small We.  Mobilizing for Three Mile Island--the disaster that wasn't. , 1979 .

[39]  S. Midorikawa,et al.  From Hiroshima and Nagasaki to Fukushima 3 Nuclear disasters and health : lessons learned , challenges , and proposals , 2015 .

[40]  長瀧 重信,et al.  Radiation health effects and countermeasures : lessons from past nuclear disasters : from atomic bomb to Fukushima , 2014 .

[41]  Makoto Misawa,et al.  System for Prediction of Environmental Emergency Dose Information Network System , 2008 .